Yingke Capital is a principal investment firm based in Fuzhou, China, founded in 2010 by Mingfei Qian. The firm specializes in pre-IPO investments and primarily focuses on sectors such as 5G internet of things, biomedical, environmental services, new energy, consumer upgrades, smart manufacturing, and materials. Yingke Capital invests in companies that demonstrate strong technology research and development capabilities, as well as significant production capacity. In addition to equity investments across all stages, from angel funding to pre-IPO, the firm also offers asset management and investment banking services.
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for the full cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease.
WestGene Biopharma
Series A in 2023
WestGene Biopharma is a high-tech enterprise dedicated to the research, development, manufacturing, and sales of mRNA therapeutics and adjuvants. The company specializes in mRNA technology to create treatments for Epstein-Barr virus-related tumors, liver cancer, and vaccines for infectious diseases, including COVID-19. WestGene holds patents in key areas such as mRNA sequences and non-viral delivery vectors. Its innovative approach incorporates machine learning for the development of 5'-UTR sequences, artificial intelligence for optimizing lipid excipients, and mathematical methods for refining new formulations. The company has established five mature technology platforms dedicated to the advancement of novel drugs, including vaccines, gene editing, and antibodies.
EnCureGen Pharmaceuticals
Seed Round in 2023
Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.
Junde Pharmaceutical
Seed Round in 2023
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for the full cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease.
Huanzhi Technology
Venture Round in 2023
Huanzhi Technology specializes in developing intelligent supply chain management solutions. The company focuses on unmanned control of industrial vehicles, logistics robots, logistics control systems, and applications related to the industrial Internet of Things. By providing these advanced technologies, Huanzhi Technology enables its clients to enhance efficiency and implement intelligent warehousing and logistics systems.
SPIC
Series B in 2022
State Power Investment Corporation Limited (SPIC) is a major player in China's energy sector, formed in 2015 through the merger of China Power Investment Corporation and State Nuclear Power Technology Corporation. With a strong focus on clean energy, SPIC boasts a total installed capacity of 126 GW across various energy sources including thermal, hydropower, nuclear, solar, and wind power. Clean energy accounts for a significant portion of its capacity, reflecting its commitment to sustainable practices. Supplying a substantial amount of power and heat annually, SPIC also has coal production, aluminum smelting, and railway transportation capabilities in its portfolio. As one of China's top five power generators, SPIC is dedicated to driving the transformation of state-owned enterprises and setting high industry standards for the future.
Huizhou Yipeng Energy Technology Co.
Series C in 2022
Huizhou Yipeng Energy Technology Co., Ltd. is a manufacturer based in Huizhou, China, specializing in lithium-ion battery systems for plug-in hybrid and pure electric vehicles. Established in 2014, the company focuses on the development and marketing of innovative energy solutions to support the growing demand for electric mobility. Its products are designed to enhance the efficiency and performance of electric vehicles, contributing to the advancement of sustainable transportation technologies.
Chengmandian Energy Technology
Series A in 2022
Chengmandian is a comprehensive provider of lithium battery energy solutions, specializing in the full life cycle management of lithium batteries. The company offers a range of services including charging, maintenance, leasing, replacement, and secondary utilization, emphasizing safe and efficient energy consumption. Chengmandian aims to innovate the application of lithium battery technology across various sectors such as shared motorcycles, battery swap systems, express delivery, and automotive industries. By focusing on digital operations and professional battery management, the company seeks to enhance energy recycling and operational efficiency, catering to both businesses and end consumers.
Dream Glass
Seed Round in 2022
Dream Glass specializes in the development of augmented reality glasses that offer portable and private virtual entertainment. The company's products are designed to deliver ultra-high-definition personal cinema and gaming experiences, allowing users to enjoy immersive entertainment anytime and anywhere. With a focus on user-friendly technology, Dream Glass's devices feature plug-and-play capabilities compatible with various mobile platforms, enhancing the overall entertainment experience for customers.
Dream Glass
Seed Round in 2022
Dream Glass specializes in the development of augmented reality glasses that offer portable and private virtual entertainment. The company's products are designed to deliver ultra-high-definition personal cinema and gaming experiences, allowing users to enjoy immersive entertainment anytime and anywhere. With a focus on user-friendly technology, Dream Glass's devices feature plug-and-play capabilities compatible with various mobile platforms, enhancing the overall entertainment experience for customers.
SolarSpace
Venture Round in 2022
SolarSpace specializes in the development, production, and sales of high-efficiency solar cells and modules designed for solar infrastructure applications. The company boasts a production capacity of 35 gigawatts, with over 95% of its output consisting of large-size cells. SolarSpace aims to deliver reliable, sustainable, and efficient photovoltaic products to the solar industry, contributing to the advancement of renewable energy solutions.
GAC Aion New Energy Automobile
Series A in 2022
GAC Aion New Energy Automobile is a Chinese manufacturer of electric vehicles, established in 2017 as a sub-brand of Guangzhou Automobile Corporation and officially launched as a marque in 2020. The company focuses on the development of new energy automobiles, aiming to deliver intelligent vehicles that enhance the driving experience for customers. GAC Aion emphasizes innovation and sustainability in its product offerings, contributing to the growing electric vehicle market in China.
Fourier
Series C in 2022
Fourier is a semiconductor company. They design a complex structure digital-analog hybrid chip. They provide products that include car audio amplifiers, mid and high-power audio amplifiers, smart audio amplifiers, SPC audio amplifiers, haptic drivers, power management, and more.
Sunwoda Electric Vehicle Battery
Series A in 2022
Sunwoda Electric Vehicle Batter provides electric vehicle battery pack solutions for new energy vehicle companies through advanced lithium battery integration technology. They built the BMS with independent intellectual property rights by dedicating their entire ability to the R&D and manufacturing of electric car battery systems, and they also built up automatic production lines for cell sorting, modules, and battery packs.
Jiuling Lithium Industry
Venture Round in 2022
Jiuling Lithium Industry is a comprehensive lepidolite utilization service provider. Its main operations include product development, manufacturing, and sales of lithium salts.
CanSemi
Private Equity Round in 2022
CanSemi is a semiconductor manufacturing company based in China, specializing in the production of microprocessors, power management chips, analog chips, and power discrete devices. The company operates as an integrated device manufacturer (IDM), focusing on addressing the domestic demand for chips in various sectors, including the Internet of Things, automotive electronics, industrial control, and 5G technology. By providing these essential components, CanSemi plays a significant role in supporting the growing technological landscape in China.
Changrong Electric
Private Equity Round in 2022
Changrong Electric specializes in the research, development, and manufacturing of motor sensor protectors, current sensors, motor controllers, drivers, and frequency inverters. The company delivers high-quality products and services across various industries, including motors, household appliances, new energy, and automobiles. By focusing on innovation and quality, Changrong Electric aims to meet the diverse needs of its clients in these sectors.
Chinagene Tech
Series A in 2022
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
Gene Vector
Seed Round in 2022
Chengdu Genevector Biotechnology Co., Ltd. is a biotechnology company specializing in the research and development of adeno-associated virus (AAV) gene therapy drugs. The company is dedicated to creating innovative therapeutics aimed at treating ophthalmic diseases, neuromuscular disorders, and various genetic and metabolic conditions. By focusing on gene therapy for significant health issues, including hereditary, cardiovascular, cerebrovascular, and neurodegenerative diseases, Genevector aims to establish a comprehensive technology chain for AAV drug development, ultimately delivering advanced biotherapy solutions to the medical field.
Boshi Hi-tech
Series B in 2022
Boshi Hi-tech develops lithium-ion battery cathode materials for research, production and sales of lithium-ion battery cathode materials.
Cloudbreak Therapeutics
Series C in 2022
Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.
Chengmandian Energy Technology
Seed Round in 2021
Chengmandian is a comprehensive provider of lithium battery energy solutions, specializing in the full life cycle management of lithium batteries. The company offers a range of services including charging, maintenance, leasing, replacement, and secondary utilization, emphasizing safe and efficient energy consumption. Chengmandian aims to innovate the application of lithium battery technology across various sectors such as shared motorcycles, battery swap systems, express delivery, and automotive industries. By focusing on digital operations and professional battery management, the company seeks to enhance energy recycling and operational efficiency, catering to both businesses and end consumers.
Aoxion Technology
Series A in 2021
Aoxion Technology is a high-tech enterprise with core handwriting AI recognition technology, committed to providing full-scene digital solutions for judicial evidence for government, enterprise and public institutions. Based on the new generation of information technology such as big data, artificial intelligence, cloud computing, and blockchain, the company provides customers with a four-in-one full-stack signing service of "digital certificate and smart signing", which fully empowers paper documents electronically and electronically. Documents are digitized and data archives are evidenced to solve the last piece of paper in the digital society.
Shanghai Union Technology
Series D in 2021
Shanghai Union Technology is an additive manufacturing company that operates in the field of industrial 3D printing. UnionTech adds value to users and improves their experiences through 3D printing technology based on 3D digital manufacturing. The company improves actual production efficiency while reducing reliance on field production personnel and truly realizing refined production process management.
UnionTech 3D
Series D in 2021
UnionTech 3D specializes in stereolithography 3D printing, an additive manufacturing technology that enables the production of highly precise and detailed polymer parts. The company develops industrial-grade 3D printers tailored for various sectors, including manufacturing, automotive, aerospace, and medical industries. In addition to manufacturing equipment, UnionTech 3D emphasizes research and development to enhance its product offerings. The company also provides technical support to facilitate the integration of 3D printing into industrial production processes.
Greatpower
Series C in 2021
Greatpower Technology specializes in the development and manufacturing of key materials for power batteries, particularly focusing on nickel sulphate, which is essential for lithium-ion batteries used in electric vehicles. The company is committed to advancing research and development in new energy resources and technologies. In addition to nickel sulphate, Greatpower produces other battery materials, including ternary precursors and lithium battery cathode materials. This approach not only enhances battery recycling efforts but also contributes to the establishment of a sustainable ecosystem within the new energy power battery industry.
Cospowers
Series B in 2021
Cospowers is a technology-driven company that specializes in developing and manufacturing smart lithium battery solutions for a global clientele. Established in 2003, the company focuses on providing a one-stop comprehensive energy storage solution, which includes rechargeable batteries, chargers, and power battery packs. Cospowers employs advanced technology and scientific management methods to ensure product safety and reliability. Their offerings cater to various applications, including network energy, electric energy storage, and consumer batteries, promoting clean and efficient energy solutions. The products are well-received by customers, reflecting the company's commitment to quality and innovation in the energy storage sector.
Tonyshare Electronic Materials Technology
Venture Round in 2021
Tongxiang Technology is an enterprise that has been focusing on the research and development of tin-coated copper strips and electronic supporting products for solar photovoltaic modules and providing related services, and can develop various professional special welding strips, copper strips, and nickel strips according to customer requirements. , Aluminum strip, etc.
SolarSpace
Series A in 2021
SolarSpace specializes in the development, production, and sales of high-efficiency solar cells and modules designed for solar infrastructure applications. The company boasts a production capacity of 35 gigawatts, with over 95% of its output consisting of large-size cells. SolarSpace aims to deliver reliable, sustainable, and efficient photovoltaic products to the solar industry, contributing to the advancement of renewable energy solutions.
Laviana Pharma
Series C in 2021
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.
Bebetter Med
Private Equity Round in 2021
Bebetter Med is a pharmaceutical research and development company that specializes in innovative small molecule oncology drugs. The firm is dedicated to the research and development of groundbreaking treatments for cancer and other serious diseases, emphasizing the creation and industrialization of new medications to address major health challenges. Through its efforts, Bebetter Med aims to contribute significantly to the advancement of cancer therapies and improve patient outcomes.
Tage Zhixing
Series B in 2021
Beijing Tage Zhixing Technology Co., Ltd. is a high-tech enterprise focusing on mining vehicle unmanned driving technology research, product development, and overall engineering solution design and implementation of unmanned mines. Tage Zhixing has launched a car-ground-cloud collaborative smart mine unmanned transportation system, which realizes cloud intelligent dispatching management, 4G.
Genuine Biotech
Series B in 2021
Genuine Biotech manufactures drugs for the treatment of viral infection, tumors, and cerebrovascular disorders.
Abogen Biosciences
Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Beijing Health Guard Biotechnology
Private Equity Round in 2021
Beijing Health Guard Biotechnology is a Beijing-based research and development company that focuses on the development of recombinant protein drugs and vaccines. Founded in 2008, the company specializes in creating novel biopharmaceuticals using a structure-guided design approach. Its primary area of expertise lies in the research and industrialization of recombinant protein vaccines, particularly for human papillomavirus (HPV). Beijing Health Guard Biotechnology is advancing multiple innovative candidate vaccines targeting various infectious diseases, with its core products including both trivalent and nonavalent HPV vaccines.
Berry Oncology
Series B in 2021
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.
JOINN Biologics
Series B in 2021
JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience, the company supports drug discovery and development through a comprehensive range of services, including molecular assessment, cGMP clinical trial materials production, commercial-scale manufacturing, and various process developments. JOINN Biologics also provides analytical and formulation development, along with documentation support for regulatory filings. The company aims to accelerate the development of high-quality biologics, thereby addressing patient needs and delivering lasting value to the biotech and biopharmaceutical sectors. By owning full intellectual property for cell line engineering, JOINN Biologics helps mitigate intellectual property issues faced by research and development organizations.
Davinci Tech
Seed Round in 2021
Davinci Tech is committed to researching and developing robotic vehicles. Its primary products are the DC100, Dafenqi electric motorcycles, and pure electric heavy-duty motorcycles.
Ab&B Biotech
Series C in 2021
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
Dingdang Health Technology Group
Venture Round in 2021
Dingdang Health Technology Group provides accessible medical products and services to address various unmet health needs. It specializes in pioneering online-to-offline solution-led real-time drug retail and medical consultation.
Dingdang Kuaiyao
Private Equity Round in 2021
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform. After users place orders on the mobile app, drugs will be delivered to their homes within half an hour.
Simcere Pharma
Series B in 2021
Simcere Pharmaceutical Group is a prominent manufacturer and distributor of pharmaceuticals based in Nanjing, China, founded in 1995. The company has transitioned from a distributor to a leading player in China's pharmaceutical market, operating five GMP-certified manufacturing facilities and maintaining a strong workforce of over 4,000 employees. Simcere's product portfolio encompasses a wide range of medications targeting various therapeutic areas, including oncology, nervous system diseases, autoimmune disorders, and infections. Notable products include recombinant human endostatin injection for lung cancer, edaravone for acute cerebral infarction, and various formulations of amoxicillin for infections. The company also develops treatments for conditions such as arthritis, diarrhea, and cardiovascular diseases. Simcere has established strategic partnerships with organizations like Bristol-Myers Squibb and Jiangsu Alphamab Biopharmaceuticals to enhance its research and development capabilities.
KUNSHAN TOPA INTELLIGENT EQUIPMENT
Post in 2021
Kunshan Topa Intelligent Equipment manufactures electronics and equipment. Their products include fuse box assembly lines, straight return conveyor lines, ECU assembly lines, and synchronous belt loop conveying lines. They provide products and sales services for the consumer electronics and transportation industry.
Aichong Biotech
Private Equity Round in 2021
Aichong Biotech is a pet biopharmaceutical company that offers product pipeline and technology content. It specializes in the production of veterinary vaccines, particularly rabies vaccines for pets, as well as other animal health products. Aichong Biotech is primarily involved in the research, development, and production of veterinary vaccines and other animal health products.
Hrain Biotechnology
Series C in 2021
Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on providing targeted treatments for cancer patients. The company specializes in Chimeric Antigen Receptor T-cell (CAR-T) therapy, which leverages biological and cellular technology to deliver precise care. Hrain Biotechnology has established clinical trial platforms and centers in multiple locations, including Beijing, Jiangsu, Chongqing, and Henan, facilitating research and development in innovative cancer treatments. By enabling clinics and hospitals to utilize advanced medical solutions, Hrain Biotechnology aims to enhance patient care and improve treatment outcomes in oncology.
Pinpianyi
Series C in 2021
Pinpianyi is a Hangzhou-based start-up that focuses on developing a smart procurement platform tailored for convenience stores. The platform utilizes artificial intelligence to offer product price data analysis and intelligent distribution ordering services, allowing convenience stores to optimize their procurement processes. By minimizing procurement and logistics costs, Pinpianyi enhances capital turnover efficiency and reduces inventory backlog for its clients. The company has successfully provided services to over 10,000 offline stores and has established connections with more than 1,000 suppliers, positioning itself as a valuable partner in the retail supply chain.
Beixin New Energy Technology
Series A in 2021
Beixin is a technology company, dedicated to providing first-class solutions and services for global new energy applications. Founded in 1999, the company is based in Qidong, China.
Ark Biosciences
Series C in 2021
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.
SMEC
Venture Round in 2021
SMEC provides foundry services focusing on technology solutions for power, connection, and sensor signal chain.
MaxPhotonics
Venture Round in 2021
MaxPhotonics is a developer and manufacturer of advanced laser technology, specializing in a range of laser devices, including pulsed, continuous wave (CW), quasi-continuous wave (QCW) fiber lasers, diode lasers, and laser cleaning machines. The company has secured 448 patents and 23 copyrights for its innovations and has achieved independent production of essential optical components such as pump sources, combiners, and isolators. These products find diverse applications in industries such as marking, engraving, cutting, welding, and additive manufacturing. MaxPhotonics aims to change industry standards by pursuing vertical integration of fiber lasers and optical devices, supported by a global sales and service network that spans Asia, Europe, America, and Oceania.
Microread
Series C in 2020
Microread is a commercialization company that focuses on sequencing technology platforms for genetic detection. They refined production processes and quality verification, and they developed a series of economical test reagents for forensic, clinical, agricultural, animal husbandry, and research fields.
Siflower Communication
Private Equity Round in 2020
Siflower Communication is a provider of wireless WiFi communication chips and solutions aimed at enhancing Internet of Things (IoT) infrastructure. Founded in 2014 and based in Shanghai, China, the company specializes in developing integrated circuit chips for WiFi wireless routers, home gateways, and related devices such as repeaters and smart home technology. Siflower's products are designed to enable faster connection speeds and improved technology for enterprises, contributing to a safer and more intelligent home environment.
MicuRx Pharmaceuticals
Series E in 2020
MicuRx Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing antibiotics to address drug-resistant bacterial infections. Founded in 2007 and headquartered in Palo Alto, California, the company has established a hybrid business model that leverages U.S. research and development alongside cost-effective scientific resources in China. MicuRx's product lineup includes MRX-I, an oral antibiotic targeting multi-drug resistant gram-positive pathogens, and its intravenous prodrug form, MRX-IV. Additionally, the company offers MRX-V, an injectable antibiotic for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company is also working on a pipeline of antibacterial drugs aimed at combating both gram-positive and gram-negative bacterial pathogens. MicuRx's subsidiary, Shanghai MicuRx, is responsible for commercializing its agents in China while global clinical studies continue.
Denovo Biopharma
Series D in 2020
Denovo Biopharma is a privately held biotechnology company focused on personalizing drug development through innovative biomarker discovery. The company has developed a unique platform and algorithm that enables the retrospective identification of genomic biomarkers using archived clinical samples. This technology is particularly beneficial for late-stage clinical drugs that have previously shown unsatisfactory efficacy, allowing for the identification of biomarkers that correlate with patient responsiveness to specific drug candidates. By leveraging this approach, Denovo Biopharma assists biotech and pharmaceutical companies in designing targeted clinical trials aimed at enhancing drug efficacy and minimizing adverse effects. The platform's applications extend across various therapeutic areas, including oncology, metabolic disorders, cardiology, immunology, and neurology.
PegBio
Private Equity Round in 2020
Founded in 2008 and based in Suzhou, PegBio is a biopharmaceutical company focused on developing innovative treatments for diabetes and obesity. The company's flagship product, PB-119, is a glucagon-like peptide 1 (GLP-1) agonist designed to improve the management of diabetes by allowing patients to take medication once a week, in contrast to the daily injections typically required. PegBio's research extends beyond diabetes, encompassing areas such as nonalcoholic fatty liver disease, gout, cardiovascular conditions, and cancer. The company aims to address significant health challenges through its advanced drug discovery efforts.
TongFu Microelectronics
Post in 2020
Tongfu Microelectronics Co., Ltd is a prominent player in the semiconductor industry, specializing in integrated circuit (IC) assembly and testing services. Established in 1997 and headquartered in Nantong, China, the company offers a diverse range of packaging solutions, including wafer-level, flip chip, ball grid array, and various plastic packaging types. Its products cater to numerous applications, including wireless communications, power management, memory, microprocessors, and automotive devices. Tongfu Microelectronics also provides comprehensive support through test platforms and engineering services for analog, mixed-signal, and digital semiconductor devices. The company's focus on meeting the demands of system manufacturers and its alignment with national industrial policies underscore its role in the coordinated development of the semiconductor supply chain. Formerly known as Nantong Fujitsu Microelectronics Co., Ltd, the company rebranded in December 2016 to reflect its growth and commitment to innovation in the semiconductor market.
Ark Biosciences
Venture Round in 2020
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.
Qihe Biotech
Venture Round in 2020
Qihe Biotech is a manufacturer based in Zibo, China, specializing in the research and development, production, processing, sales, and export of edible fungi. The company serves a variety of international markets and offers technical guidance services to customers in different regions, ensuring a comprehensive approach to the distribution and utilization of its products.
WM Motor
Series D in 2020
WM Motor is an automotive company that designs, manufactures, develops, and markets energy and battery-operated vehicles. It provides energy vehicle products and travel solutions to its customers. The company aims to conserve electronic vehicles in addition to intelligent data hardware, enabling consumers to utilize smart cars that are efficient and energy conserving. WM Motor’s products are built with three core technologies, the Living Motion electric powertrain, the Living Pilot intelligent driving assistance system, and the Living Engine operating system, which offers industry-leading smart connectivity and interactive features.
Adlai Nortye
Series C in 2020
Adlai Nortye Biopharma Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative cancer therapies and treatments for metabolic diseases. Founded in 2004 and based in Hangzhou, China, the company has established research and development and clinical operations in both China and the United States. Adlai Nortye has a diverse pipeline of over ten drug candidates, including several in various stages of clinical development, such as buparlisib (AN2025), palupiprant (AN0025), and AN4005, alongside preclinical candidates like AN8025, AN9025, and AN1025. The company emphasizes collaborations and internal discoveries to advance its strategic focus on oncology.
Robint
Venture Round in 2020
Beijing Robint Technology Co. Ltd. is a technology hardware company based in Beijing, China, specializing in the research, development, design, production, and sale of artificial intelligence robots. The company offers a range of products, including intelligent service robots, delivery robots, distribution containers, and food delivery robots. Robint focuses on developing patented core technologies in areas such as precise perception, intelligent identification, human-like cognition, collaborative decision-making, and high-precision mapping and motion control, positioning itself as a significant player in the AI robotics sector.
Hanyu Medical
Series D in 2020
Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices, focusing on innovative solutions for heart valve diseases. Its primary product, Valve Clamp, is an interventional device designed for minimally invasive treatment of mitral valve regurgitation. This device facilitates the closure of heart valves during operations, allowing surgeons to perform heart surgeries with reduced invasiveness. Hanyu Medical's commitment to advancing medical technology positions it as a significant player in the cardiovascular device market.
COSMX
Private Equity Round in 2020
COSMX specializes in the research, development, production, and sales of consumer polymer soft-pack lithium-ion batteries. The company serves a diverse range of sectors, including notebook computers, tablet computers, smartphones, smart wearables, power tools, and drones. By focusing on innovative battery technology, COSMX aims to meet the growing demand for efficient and lightweight energy storage solutions in various consumer electronics and industrial applications.
LaNova Medicines
Series A in 2020
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Asieris Pharmaceuticals
Series C in 2020
Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010, headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris is committed to advancing therapeutic solutions that integrate both diagnosis and treatment, catering to the needs of patients in China and globally. Through its innovative approach, the company seeks to contribute significantly to the fields of oncology and infectious disease management.
LaNova Medicines
Seed Round in 2020
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
EOC Pharma Group
Series C in 2019
EOC Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. The company specializes in developing, manufacturing, and commercializing innovative oncology products, utilizing a licensing model to enhance its product pipeline. EOC partners with global biopharmaceutical firms to integrate their molecules into its local manufacturing and regulatory frameworks. The company currently has a pipeline of seven novel products, four of which have received Class I innovative drug approvals and are undergoing clinical studies in China. EOC operates an 8,000 square meter cGMP manufacturing facility in Taizhou, China Medical City, and maintains offices in major cities, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team experienced in pharmaceutical research and development, EOC aims to position itself as a leader in oncology innovation within China.
THOK LOGISTICS
Venture Round in 2019
THOK LOGISTICS provides solution services for supply chain logistics integrating consulting planning, system integration, logistics technology equipment product manufacturing, and software system research and development. It is a supply chain logistics solution provider.
Phylion Battery
Private Equity Round in 2019
Phylion Battery is a manufacturer based in Suzhou, China, specializing in the development, production, and sales of lithium-ion batteries. Utilizing lithium manganate as its positive electrode material, the company has established an annual production capacity of 5GWh. With over 15 years of experience in technology transformation, Phylion has successfully served 8 million end users and provided battery solutions for more than 45,000 electric vehicles globally. The company is recognized as a high-tech enterprise in the power lithium battery sector and is actively involved in research and development within the energy storage field. Phylion is committed to delivering innovative power supply solutions for new energy vehicles and various industrial applications worldwide.
Voc Acoustic Technology
Series A in 2019
Hunan Voc Acoustic Technology Co., Ltd. is a Chinese company specializing in the development, manufacture, and sale of acoustic products, including headphones, Bluetooth earphones, high-fidelity audio devices, and smart speakers. Founded in 2017 and based in Zhuzhou, the company engages in comprehensive acoustic technology services, integrating research and development with production and sales. Voc Acoustic Technology has entered the true wireless stereo (TWS) headset market and offers acoustic research and production services to brands globally, catering to both domestic and international clients.
Haihe Biopharma
Series B in 2019
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.
Heng Yi Biotechnology
Venture Round in 2019
Heng Yi Biotechnology Co., Ltd. is a manufacturer of nutritional and dietary supplements based in Taichung, Taiwan, established in 1974. The company specializes in creating high-quality products using natural ingredients and raw materials. Its diverse product range includes food ingredients, essential oils, fragrances, beverages, confectionery items, organic products, healthcare products, pharmaceutical ingredients, and spray dry powder. Essential oils are available in various series, such as flower, plant, and fruit, while fragrances encompass a wide array of applications, including personal care and household products. Additionally, Heng Yi engages in the import and export of food raw materials, ensuring a strong presence in both domestic and international markets. The company is committed to maintaining stringent quality standards throughout the manufacturing, storage, distribution, and sales processes.
Hanyu Medical
Series B in 2018
Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices, focusing on innovative solutions for heart valve diseases. Its primary product, Valve Clamp, is an interventional device designed for minimally invasive treatment of mitral valve regurgitation. This device facilitates the closure of heart valves during operations, allowing surgeons to perform heart surgeries with reduced invasiveness. Hanyu Medical's commitment to advancing medical technology positions it as a significant player in the cardiovascular device market.
Chunmi
Series C in 2018
Chunmi Technology, founded in 2013 and headquartered in Shanghai, China, specializes in the development and manufacturing of smart kitchen appliances. The company offers a range of products, including rice cookers, ovens, and microwaves, all designed to enhance the cooking experience through the integration of Internet of Things (IoT) technology. Chunmi's appliances connect to a mobile application, allowing users to monitor and control their cooking processes conveniently from their smartphones. This focus on innovation aims to provide a seamless and efficient cooking experience for consumers.
Royole
Series E in 2018
Royole Corporation is a global leader in the development and manufacturing of advanced flexible displays, flexible sensors, and innovative smart devices. The company specializes in foldable smartphones and tablets, smart writing pads, wearables, and mobile theaters, offering products such as the FlexPai smartphone, RoWrite smart writing pad, and Moon mobile theater. Headquartered in Fremont, California, with an additional office in Shenzhen, China, Royole provides tailored solutions across various industries, including consumer electronics, automotive, computing, and telecommunications. Its display technology ranges from small panels for handheld devices to large high-resolution screens. The company also engages in consulting services and has established a strategic partnership with JD.COM to enhance its market reach through online sales. Founded in 2012, Royole continues to push the boundaries of flexible electronics to meet the evolving needs of consumers and businesses alike.
Huizhou Yipeng Energy Technology Co.
Corporate Round in 2018
Huizhou Yipeng Energy Technology Co., Ltd. is a manufacturer based in Huizhou, China, specializing in lithium-ion battery systems for plug-in hybrid and pure electric vehicles. Established in 2014, the company focuses on the development and marketing of innovative energy solutions to support the growing demand for electric mobility. Its products are designed to enhance the efficiency and performance of electric vehicles, contributing to the advancement of sustainable transportation technologies.
Health Engine
Corporate Round in 2018
Health Medical Technology is engaged in the intelligent management of medical equipment. They provide internet of things tools such as the self-developed equipment asset management platform and remote equipment management system, which realize the dynamics of intelligentization and dataization of the entire life cycle of medical equipment. They improve the efficiency of equipment operation, and realize the refined management of medical equipment through the mining and application of big data in medical equipment management.
Kanghua Biotechnology
Angel Round in 2018
Kanghua Biotechnology is a manufacturer based in Weifang, China, specializing in the development of biochemical reagents and in vitro diagnostic (IVD) products. Established in 1996, the company produces a wide range of diagnostic tools, including rapid test kits for fertility, hepatitis, infectious diseases, and tumor markers, as well as ELISA kits for blood screening and other medical assessments. Their offerings cater to diverse areas such as prenatal and postnatal care, respiratory and digestive tract diagnostics, and rheumatic diseases. Kanghua Biotechnology is committed to providing medical facilities with reliable diagnostic supplies and equipment, supporting accurate disease diagnosis and patient care.
Chengdu Kanghua Biological Products
Private Equity Round in 2018
Kanghua Biological is a research and development, production, and operation of preventive biological products. The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 group Meningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department. It was founded in 2004 in Chengdu, Sichuan, China.
LEADTHING
Post in 2018
LEADTHING is a software and information technology service company. They provide corresponding software products and solutions for customer information. Their products cover institutions, military, public security, and border defense.
JHOME
Post in 2018
JHOME is an import and export rights company and an Internet B2C sales platform for drugs and medical devices. Their production and sales of in vitro diagnostic reagents and instruments, medical imaging, and medical electronic equipment. They focus on product and technological innovation in the fields of medical care, family health, and public safety.
JAKI
Post in 2018
JAKI product research and development, and promotes development. They provides delivery services like .211 limited time, delivery service inquiry, shipping fee charging standard and overseas delivery. They also provides online education for the kids.
34learning
Seed Round in 2018
34learning provides products and services such as digital learning solutions, micro-consulting projects, mixed project courses, and traditional courses. They also offer online learning development solutions for their partners. Their courses include mixed learning, leadership development, professional development, personal ability development, and others.
Goldpro
Corporate Round in 2017
Goldpro is one professional manufacturer and exporter of grinding media steel balls in China. Besides supplying different sizes of grinding steel balls, the company also provides other services, like developing new special steel balls according to the ore conditions for its customers.
11ziyun.com
Post in 2017
11ziyun.com is a printing paper company. Their service platform spans e-commerce, logistics, cloud computing, big data, and cross border transaction services. They offer advertising materials, commercial printing, digital printing materials, design services, office supplies, student supplies, and paper pulps.
LC Securities
Series B in 2017
LC Securities is an integrated financial services platform in Guangdong. The company provides credit business, fixed income, and asset management services. The business focuses on offering Chinese high-net-worth individuals professional, effective, and convenient one-stop financing services.
Yondervision
Post in 2017
Yondervision is a technology company that specializes in providing digital solutions for housing provident funds and financial services. The company offers customized software development, maintenance services, and third-party product integration for housing provident fund management agencies and banks. Its business encompasses five main sectors: digital provident fund management, digital financial services, service outsourcing, data intelligence services, and a digital platform for information sharing. Yondervision is dedicated to the housing finance sector, delivering high-quality services that include statistical reporting and data analysis tools. Through its comprehensive offerings, the company aims to enhance the efficiency and effectiveness of financial operations related to housing provident funds.
Shanghai Sanyou Medical
Private Equity Round in 2017
Shanghai Sanyou Medical Co., Ltd specializes in the research and development, manufacturing, and sales of innovative orthopedic implants and medical devices. The company is located in the Medical Apparatus Garden of Zhangjiang Hi-Tech Park in Shanghai. Its product range includes type III implantation equipment for orthopedics, type III intracranial hematoma puncture removal equipment, as well as various types of surgical instruments and nursing materials. Since its restructuring in September 2010, the company has aimed to establish a sustainable and valuable presence in the medical device industry.
KUNSHAN TOPA INTELLIGENT EQUIPMENT
Venture Round in 2017
Kunshan Topa Intelligent Equipment manufactures electronics and equipment. Their products include fuse box assembly lines, straight return conveyor lines, ECU assembly lines, and synchronous belt loop conveying lines. They provide products and sales services for the consumer electronics and transportation industry.
Bright Key
Series A in 2017
Bright Key provides SAP services. They also provide consulting, implementation, operation, and maintenance services of SAP software products, including implementation services of various application modules of the SAP ERP system, enterprise SAP ERP system before receiving external audit consulting services, daily operation and maintenance, technical support, and tuning services of SAP ABAP and SAP Java programs, and more.
SMO ClinPlus
Venture Round in 2016
SMO ClinPlus Co., Ltd. is a Shanghai-based company that specializes in clinical trial and site management organization (SMO) services. Founded in 2009 and rebranded in 2016, the firm caters to both domestic and international pharmaceutical and medical device companies, as well as those involved in the clinical research and development of health-related products. The company offers a range of services, including the establishment of preliminary models, preparation of initial plans, initiation of clinical trial sites, on-site implementation, and comprehensive project management, ensuring effective support throughout the clinical trial process.
Zelgen
Series A in 2016
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the research, development, manufacturing, and sales of innovative medications. The company focuses on creating new chemical and biological drugs for a range of therapeutic areas, including cancer, hematologic diseases, and hepatobiliary conditions. Zelgen aims to address unmet medical needs within the domestic market by providing high-quality, safe, effective, and affordable treatment options. Through its commitment to innovation and R&D, Zelgen aspires to establish itself as a leading player in the Chinese biopharmaceutical sector.
SMO ClinPlus
Venture Round in 2016
SMO ClinPlus Co., Ltd. is a Shanghai-based company that specializes in clinical trial and site management organization (SMO) services. Founded in 2009 and rebranded in 2016, the firm caters to both domestic and international pharmaceutical and medical device companies, as well as those involved in the clinical research and development of health-related products. The company offers a range of services, including the establishment of preliminary models, preparation of initial plans, initiation of clinical trial sites, on-site implementation, and comprehensive project management, ensuring effective support throughout the clinical trial process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.